je.st
news
Tag: clinical
DanDrit Biotech A/S Signs Agreement to Commence Clinical Trials of MelCancerVac
2014-10-01 11:13:37| Biotech - Topix.net
DanDrit Biotech A/S , the subsidiary of DanDrit Biotech USA, Inc. , a biotechnology company seeking to develop an approved vaccine for the treatment of colorectal cancer, signed a contract of collaboration with the University Hospital IRCCS "San Martino" - IST - National Institute for Cancer Research known as the San Martino Hospital of Genoa. Dr. Alberto Sobrero, the Head of the Medical Oncology Unit at the San Martino Hospital is principal investigator of the randomized multicenter study.
Tags: agreement
signs
clinical
trials
ViewRay to Showcase World's Only MRI-Guided Radiation Therapy System In Clinical Use at ...
2014-09-12 06:00:00| Industrial Newsroom - All News for Today
Doctors from Leading Cancer Center Will Discuss Firsthand Experience with MRIdian's Adaptive and Soft-Tissue Tracking Capabilities<br /> <br /> CLEVELAND - ViewRay™, a privately held medical device company, announced today that it will showcase its MRIdian™ (me-rid-i-an) system, the world's first and only MRI-guided radiation therapy system, at the 56(th) Annual Meeting of the American Society for Radiation Oncology (ASTRO) being held September 14-17, 2014 in San Francisco. ...This story is related to the following:Vision SystemsSearch for suppliers of: Medical Imaging Systems
Tags: use
system
clinical
therapy
Tools for the Design of Vaccines to Help Reduce Clinical Failure
2014-09-11 16:23:44| drugdiscoveryonline Home Page
If you are involved in the pharma industry, then you are interested in saving lives. In the area of preventative medicine, therapeutic vaccines have proven to have a tremendous impact on the ability to save millions of lives. Similar to pharmaceuticals, vaccine development can take over 10 years and less than 10 percent of candidates reach commercialization. Reducing the cost of failure and increasing the chances of clinical success for vaccines is beneficial to both the pharma industry and those being treated for or protected from disease. Dr. Noel Smith, Senior Group Leader, Lonza Biologics Lonza understands this need and how ensuring the design and development of efficacious vaccines is critical for worldwide health. To address this, Dr. Noel Smith, Senior Group Leader, and the Applied Protein Services team at Lonza launched the Epibase™ Platform of in silico and in vitro immunogenicity screening services to help increase the chances of success for anyone aiming to develop safe and potent vaccines. “Our tools help researchers in the discovery stage of vaccine design and development to optimize their molecules before they progress into manufacturing for clinical trials,” says Dr. Smith. “Early assessment and optimization of immune responses allows you to focus your R&D resources on a smaller number of vaccine candidates with the greatest chance of success.”
Tags: design
tools
reduce
failure
ViewRay's MRIdian Makes Adaptive Radiation Therapy a Clinical Reality
2014-09-09 06:00:00| Industrial Newsroom - All News for Today
World's First On-Table Adaptive Radiation Therapy Clinical Program Commenced at Siteman Cancer Center<br /> <br /> CLEVELAND, -- ViewRay(TM) Incorporated, a privately held medical device company, announced today that the world's first on-table adaptive radiation treatment program using the MRIdian(TM) (me-rid-i-an) system began at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis. The MRIdian system provides a patented combination ...This story is related to the following:Magnetic Resonance Imaging (MRI) Scanners
Tags: makes
reality
clinical
therapy
Ultrasound System targets research and clinical applications.
2014-09-08 14:31:27| Industrial Newsroom - All News for Today
Featuring software beamforming technology and frame rate of over 9,000 fps, E-CUBE 12R can acquire high-resolution raw RF data in real-time. System offers arbitrary waveform generation and highly customizable sequence programmability that allows researchers to manipulate all parameters, including transmit level, receive level, and transducer settings. Users can also freely process and reconstruct pre-beamformed and post-beamformed non-decimated pixel RF data in system environment. This story is related to the following:Health, Medical and Dental Supplies and EquipmentUltrasound Systems | Medical Diagnostic Equipment |
Tags: system
research
applications
clinical
Sites : [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] next »